Research News and Research

RSS

Selexis SA and NKT Therapeutics sign research services agreement

Selexis SA ("Selexis") and NKT Therapeutics, Inc. ("NKTT") announce today that they have entered into a research services agreement whereby Selexis will screen antibody variants and generate high performance CHO-based production cell lines using their novel platform named INTEGRA-D2M(TM).

2 Sep 2009

Gene causing periodontitis, rheumatoid arthritis and osteoporosis identified

Investigators at Hospital for Special Surgery, collaborating with researchers from other institutions, have contributed to the discovery that a gene called interferon regulator factor-8 (IRF-8) is involved in the development of diseases such as periodontitis (gum disease), rheumatoid arthritis and osteoporosis. The study, which will be published online August 30, ahead of print, in the journal Nature Medicine, could lead to new treatments in the future.

2 Sep 2009

Future Alzheimer's treatments may be effective before the onset of symptoms

Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.

2 Sep 2009

The 2009 H1N1 influenza virus causes more severe disease than human seasonal influenza viruses

Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Tests in animals showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains, and the new virus caused more severe disease. In line with previous findings by other research groups, the University of Maryland researchers also observed that the novel H1N1 virus was transmitted more easily from infected to uninfected ferrets than either of the two seasonal influenza viruses.

2 Sep 2009

Research is active and diverse in U.S. academic medical centers

A survey indicates that research is active and diverse at U.S. academic medical centers and that a substantial proportion of faculty conduct research and publish without sponsorship, according to a study in the September 2 issue of JAMA.

2 Sep 2009

Strategy to enhance diabetes management across Canada

Research being driven by The University of Western Ontario that will enhance diabetes management across Canada recently received support from two of Canada's leading pharmaceutical companies in the form of a $500,000 contribution.

2 Sep 2009

Lupus Foundation of America to educate people with lupus on clinical trial participation

It has been more than 50 years since the U.S. Food and Drug Administration (FDA) last approved a new medicine specifically for lupus – when Dwight D. Eisenhower was president. Existing treatments have been "borrowed" from other disorders and the risk/benefit ratio of these treatments is far from optimal. However, hope is on the horizon.

2 Sep 2009

Public-private collaboration to fund research on health, diet and green technology

A total of £7M funding has been announced today by two public-private collaborations led by the Biotechnology and Biological Sciences Research Council (BBSRC).

2 Sep 2009

SBIR subcontract awarded to Novint Technologies to develop a videogame for soldiers suffering from TBI

Novint Technologies, Inc. (OTCBB: NVNT) today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) subcontract to develop a videogame that will improve cognitive, motor, and sensory performance in soldiers suffering from traumatic brain injury (TBI). The SBIR was awarded by the Office of the Secretary of Defense (OSD) Defense Health Program.

2 Sep 2009

SAGE forges agreement with the International Headache Society

SAGE, the world's leading independent academic and professional publisher is delighted to announce a new agreement with the International Headache Society (IHS) to publish their official journal, Cephalalgia.

2 Sep 2009

Defibrillator-cardiac resynchronization therapy combination reduces heat failure risk

Patients who had a cardiac resynchronization device combined with a defibrillator (CRT-D) implanted had a 34 percent reduction in their risk of death or heart failure when compared to patients receiving only an implanted cardiac defibrillator (ICD), according to a landmark study published online today in the New England Journal of Medicine and presented today at the European Society of Cardiology Congress (ESC) in Barcelona, Spain.

2 Sep 2009

Novo Nordisk's NCDP provides support for accurate cost and benefit assessments of preventive health

The National Changing Diabetes((R) )Program (NCDP), a program of Novo Nordisk, commends Representative Donna M. Christensen, M.D. (D-VI) and Michael C. Burgess, M.D. (R-TX) for sponsoring legislation that will lead to a more accurate assessment of the cost and benefits of preventive health, including preventing complications and delaying progression of chronic diseases such as diabetes.

From Novo Nordisk 2 Sep 2009

LINGO1 variant responsible for essential tremors and Parkinson's disease

Researchers at the Mayo Clinic campus in Florida and their collaborators worldwide have discovered that a single gene promotes development of essential tremor in some patients and Parkinson's disease in others.

2 Sep 2009

Linkwell concerned with misunderstanding of prevention and control measures of H1N1

Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare-related disinfectants in China, put forward its worries about the trend of the misunderstanding concerning dealing with the spread of H1N1.

2 Sep 2009

STEMCELL Technologies to conduct a two-day stem cell training program

STEMCELL Technologies has announced the schedule for their fall training program. This includes 2-day courses on mesenchymal stem cell biology (October 2nd and 3rd), mammary stem cell biology (October 17th and 18th), neural stem cell biology (October 30th and 31st), hematopoietic stem cell biology (October 30th and 31st), and human embryonic and induced pluripotent stem cell biology (November 14th and 15th).

2 Sep 2009

Structural MRI for early diagnosis of neurodegenerative disorders

A new Mayo Clinic study may help physicians differentially diagnose three common neurodegenerative disorders in the future. The study will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 11 in Vienna.

2 Sep 2009

Mistrust of healthcare system could harm patients' health and raise overall health care costs

Mistrust among patients, providers and insurers could harm patients' health and raise overall health care costs, reports a new study.

2 Sep 2009

Financial rewards motivate America's workers to participate in wellness programs

America's workers will take greater responsibility for their health and participate in corporate wellness programs if there is a financial incentive, according to a survey released today by Virgin HealthMiles, a leading provider of health and productivity programs. Eighty nine percent of the 2,700 U.S. employees surveyed said financial rewards (e.g., cash, healthcare premium discounts) are important motivators for participating in wellness programs.

2 Sep 2009

Expanding health centers to reach more patients will result in huge health care savings

Expanding health centers to reach an additional 20 million patients as part of national health reform would result in overall health care savings of $212 billion over the ten-year period 2010 to 2019, including federal Medicaid savings of $59 billion.

2 Sep 2009

Monsanto sings a non-exclusive research and commercial license agreement with Cellectis

Monsanto Company (NYSE:MON) today announced a non-exclusive research and commercial license agreement with France-based Cellectis S.A. (Paris:ALCLS), a biotechnology company specialized in genome engineering, for broad use of its meganuclease technology in plants.

2 Sep 2009

Research News and Research

Selexis SA and NKT Therapeutics sign research services agreement

Gene causing periodontitis, rheumatoid arthritis and osteoporosis identified

Future Alzheimer's treatments may be effective before the onset of symptoms

The 2009 H1N1 influenza virus causes more severe disease than human seasonal influenza viruses

Research is active and diverse in U.S. academic medical centers

Strategy to enhance diabetes management across Canada

Lupus Foundation of America to educate people with lupus on clinical trial participation

Public-private collaboration to fund research on health, diet and green technology

SBIR subcontract awarded to Novint Technologies to develop a videogame for soldiers suffering from TBI

SAGE forges agreement with the International Headache Society

Defibrillator-cardiac resynchronization therapy combination reduces heat failure risk

Novo Nordisk's NCDP provides support for accurate cost and benefit assessments of preventive health

LINGO1 variant responsible for essential tremors and Parkinson's disease

Linkwell concerned with misunderstanding of prevention and control measures of H1N1

STEMCELL Technologies to conduct a two-day stem cell training program

Structural MRI for early diagnosis of neurodegenerative disorders

Mistrust of healthcare system could harm patients' health and raise overall health care costs

Financial rewards motivate America's workers to participate in wellness programs

Expanding health centers to reach more patients will result in huge health care savings

Monsanto sings a non-exclusive research and commercial license agreement with Cellectis

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics